Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury

F Cattel, S Giordano, C Bertiond, T Lupia… - Respiratory physiology …, 2021 - Elsevier
Several pre-clinical and clinical trials show that exogenous pulmonary surfactant has clinical
efficacy in inflammatory lung diseases, especially ARDS. By infecting type II alveolar cells …
被引用次数：38 相关文章

Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury

F Cattel, S Giordano, C Bertiond… - Respiratory …, 2021 - pubmed.ncbi.nlm.nih.gov
Several pre-clinical and clinical trials show that exogenous pulmonary surfactant has clinical
efficacy in inflammatory lung diseases, especially ARDS. By infecting type II alveolar cells …

Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): role in SARS-CoV-2-related lung injury.

F Cattel, S Giordano, C Bertiond, T Lupia, S Corcione… - 2021 - cabidigitallibrary.org
Several pre-clinical and clinical trials show that exogenous pulmonary surfactant has clinical
efficacy in inflammatory lung diseases, especially ARDS. By infecting type II alveolar cells …

Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury

F Cattel, S Giordano, C Bertiond, T Lupia… - RESPIRATORY …, 2021 - iris.unito.it
Several pre-clinical and clinical trials show that exogenous pulmonary surfactant has clinical
efficacy in inflammatory lung diseases, especially ARDS. By infecting type II alveolar cells …
[HTML] nih.gov

[HTML][HTML] Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury

F Cattel, S Giordano, C Bertiond, T Lupia… - Respiratory …, 2021 - ncbi.nlm.nih.gov
Several pre-clinical and clinical trials show that exogenous pulmonary surfactant has clinical
efficacy in inflammatory lung diseases, especially ARDS. By infecting type II alveolar cells …

Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury.

F Cattel, S Giordano, C Bertiond, T Lupia… - Respiratory …, 2021 - europepmc.org
Several pre-clinical and clinical trials show that exogenous pulmonary surfactant has clinical
efficacy in inflammatory lung diseases, especially ARDS. By infecting type II alveolar cells …

Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury

F Cattel, S Giordano, C Bertiond… - Respiratory …, 2021 - pubmed.ncbi.nlm.nih.gov
Several pre-clinical and clinical trials show that exogenous pulmonary surfactant has clinical
efficacy in inflammatory lung diseases, especially ARDS. By infecting type II alveolar cells …